UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (267) 267
life sciences & biomedicine (257) 257
oncology (220) 220
humans (215) 215
male (137) 137
female (132) 132
middle aged (120) 120
aged (118) 118
lung neoplasms - drug therapy (97) 97
adult (89) 89
carcinoma, non-small-cell lung - drug therapy (86) 86
lung cancer (80) 80
antineoplastic combined chemotherapy protocols - therapeutic use (69) 69
lung neoplasms - pathology (64) 64
chemotherapy (58) 58
cancer (56) 56
treatment outcome (55) 55
aged, 80 and over (53) 53
neoplasm staging (53) 53
mutation (50) 50
respiratory system (49) 49
carcinoma, non-small-cell lung - pathology (48) 48
care and treatment (47) 47
lung cancer, non-small cell (44) 44
lung neoplasms - genetics (43) 43
lung neoplasms - mortality (42) 42
prognosis (41) 41
human necessities (40) 40
hygiene (40) 40
medical or veterinary science (40) 40
preparations for medical, dental, or toilet purposes (40) 40
tumors (40) 40
specific therapeutic activity of chemical compounds ormedicinal preparations (39) 39
antineoplastic agents - therapeutic use (37) 37
carcinoma, non-small-cell lung - mortality (37) 37
disease-free survival (36) 36
carcinoma, non-small-cell lung - genetics (35) 35
clinical trials (35) 35
hematology, oncology and palliative medicine (35) 35
cancer therapies (34) 34
analysis (31) 31
patients (30) 30
cisplatin - administration & dosage (29) 29
non-small cell lung carcinoma (28) 28
antineoplastic combined chemotherapy protocols - adverse effects (27) 27
survival analysis (27) 27
metastasis (26) 26
nsclc (26) 26
survival rate (26) 26
abridged index medicus (25) 25
kaplan-meier estimate (25) 25
pulmonary and respiratory medicine (24) 24
antineoplastic agents (22) 22
biomarkers (21) 21
research (21) 21
chemistry (20) 20
general & internal medicine (20) 20
immunotherapy (20) 20
lung neoplasms - metabolism (20) 20
antibodies, monoclonal - administration & dosage (19) 19
lung neoplasms - therapy (19) 19
medicine, general & internal (19) 19
metallurgy (19) 19
non-small cell lung cancer (19) 19
pemetrexed (19) 19
protein kinase inhibitors - therapeutic use (19) 19
disease progression (18) 18
medicine (18) 18
medicine & public health (18) 18
neoplasms - drug therapy (18) 18
non-small-cell lung cancer (18) 18
double-blind method (17) 17
drug therapy (17) 17
follow-up studies (17) 17
pathology (17) 17
pulmonary/respiratory (17) 17
receptor, epidermal growth factor - genetics (17) 17
animals (16) 16
antimitotic agents (16) 16
apoptosis (16) 16
carboplatin - administration & dosage (16) 16
cisplatin (16) 16
tyrosine (16) 16
antineoplastic agents - adverse effects (15) 15
biomarkers, tumor - metabolism (15) 15
cancer research (15) 15
guanine - analogs & derivatives (15) 15
hematology (15) 15
patient outcomes (15) 15
studies (15) 15
survival (15) 15
antibodies, monoclonal - therapeutic use (14) 14
biochemistry (14) 14
carcinoma, non-small-cell lung - therapy (14) 14
cell biology (14) 14
drug administration schedule (14) 14
egfr (14) 14
erbb receptors - genetics (14) 14
genetic aspects (14) 14
infusions, intravenous (14) 14
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (556) 556
Spanish (22) 22
French (20) 20
German (10) 10
Bulgarian (2) 2
Czech (2) 2
Norwegian (2) 2
Polish (2) 2
Portuguese (2) 2
Chinese (1) 1
Danish (1) 1
Slovak (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 09/2009, Volume 361, Issue 10, pp. 958 - 967
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 08/2017, Volume 35, Issue 22, pp. 2490 - 2498
Journal Article
The lancet oncology, ISSN 1470-2045, 07/2015, Volume 16, Issue 7, pp. 763 - 774
Journal Article
by Rosell, Rafael and Carcereny, Enric and Gervais, Radj and Vergnenegre, Alain and Massuti, Bartomeu and Felip, Enriqueta and Palmero, Ramon and Garcia-Gomez, Ramon and Pallares, Cinta and Sanchez, Jose Miguel and Porta, Rut and Cobo, Manuel and Garrido, Pilar and Longo, Flavia and Moran, Teresa and Insa, Amelia and De Marinis, Filippo and Corre, Romain and Bover, Isabel and Illiano, Alfonso and Dansin, Eric and de Castro, Javier and Milella, Michele and Reguart, Noemi and Altavilla, Giuseppe and Jimenez, Ulpiano and Provencio, Mariano and Moreno, Miguel Angel and Terrasa, Josefa and Muñoz-Langa, Jose and Valdivia, Javier and Isla, Dolores and Domine, Manuel and Molinier, Olivier and Mazieres, Julien and Baize, Nathalie and Garcia-Campelo, Rosario and Robinet, Gilles and Rodriguez-Abreu, Delvys and Lopez-Vivanco, Guillermo and Gebbia, Vittorio and Ferrera-Delgado, Lioba and Bombaron, Pierre and Bernabe, Reyes and Bearz, Alessandra and Artal, Angel and Cortesi, Enrico and Rolfo, Christian and Sanchez-Ronco, Maria and Drozdowskyj, Ana and Queralt, Cristina and de Aguirre, Itziar and Ramirez, Jose Luis and Sanchez, Jose Javier and Molina, Miguel Angel and Taron, Miquel and Paz-Ares, Luis and on behalf of the Spanish Lung Cancer Group in collaboration with the Groupe Français de Pneumo-Cancérologie and the Associazione Italiana Oncologia Toracica and Assoc Italiana Oncologia Toracica and Grp Francais Pneumocancerologie and Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia Toracica
The lancet oncology, ISSN 1470-2045, 03/2012, Volume 13, Issue 3, pp. 239 - 246
Summary Background Erlotinib has been shown to improve progression-free survival compared with chemotherapy when given as first-line treatment for Asian... 
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Erlotinib Hydrochloride | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Prospective Studies | Exons | Lung Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | Cisplatin - administration & dosage | Patient Selection | Time Factors | Female | Quinazolines - administration & dosage | Precision Medicine | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Lung Neoplasms - enzymology | Drug Administration Schedule | Administration, Oral | Carcinoma, Non-Small-Cell Lung - genetics | Deoxycytidine - administration & dosage | Europe | Kaplan-Meier Estimate | Proportional Hazards Models | Carboplatin - administration & dosage | Treatment Outcome | Chi-Square Distribution | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Quinazolines - adverse effects | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Mutation | Deoxycytidine - analogs & derivatives | Antimitotic agents | Care and treatment | Chemotherapy | Erlotinib | Lung cancer | Product development | Agriculture | Lung cancer, Non-small cell | Antineoplastic agents | Standards | Cancer | Index Medicus
Journal Article
Journal of thoracic oncology, ISSN 1556-0864, 12/2019, Volume 14, Issue 12, pp. 2120 - 2132
The ROS1 gene rearrangement has become an important biomarker in NSCLC. The College of American Pathologists/International Association for the Study of Lung... 
Immunohistochemistry | FISH | Lung carcinoma | Next-generation sequencing | ROS1 | Respiratory System | Oncology | Life Sciences & Biomedicine | Science & Technology
Journal Article
The lancet oncology, ISSN 1470-2045, 03/2015, Volume 16, Issue 3, pp. 328 - 337
Journal Article